long intergenic non-protein coding RNA 1985Genealiases: []
Q-omics provides the consensus-scored LINC01985 profile across patient tissues and cancer cell-line models. LINC01985 expression is associated with patient survival in 17 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, LINC01985 is differentially expressed in 16, with the highest sampling consensus in COAD. Additionally, LINC01985 RNA expression shows 10,054 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight ACC, COAD, and THYM as cancer lineages where LINC01985 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01985 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01985 survival associations across molecular data types. LINC01985 RNA expression shows survival associations in the most cancer types (17). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01985 RNA expression–survival associations across cancer types. High LINC01985 expression shows unfavorable associations in UVM and STAD, but favorable associations in ACC, LIHC, THCA and SARC. The ACC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for LINC01985 RNA expression.
This table summarizes LINC01985 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 16. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01985. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01985 shows lower tumor expression in COAD, THCA, BLCA, LUAD, KIRP and LUSC. The COAD box plot shows higher LINC01985 RNA expression in normal versus tumor tissue (log2 FC = −0.841, t-test p < 0.001).
This table shows molecular features associated with LINC01985 in patient tissues and cancer cell lines. In patient samples, LINC01985 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
